After forming from a merger hashed…
After forming from a merger hashed out over plates of [...]
In a highly anticipated article,…
In a highly anticipated article, FDA officials Vinay Prasad, M.D., [...]
AbbVie is ending an 11-year…
AbbVie is ending an 11-year agreement with Alphabet’s Calico Labs, [...]
Pfizer on Monday unveiled seven…
Pfizer on Monday unveiled seven near-term trials of its PD-1xVEGF [...]
Novo Nordisk has reported the…
Novo Nordisk has reported the mixed midphase results behind its [...]
As Neuphoria Therapeutics…
As Neuphoria Therapeutics considers its options in the wake of [...]
CeleCor presented the results of…
CeleCor presented the results of its pivotal CeleBrate phase 3 [...]
Voyager Therapeutics is shoving…
Voyager Therapeutics is shoving off on a new journey to [...]
Cogent Biosciences has cleared…
Cogent Biosciences has cleared another phase 3 hurdle for its [...]
After a chaotic and fierce bidding…
After a chaotic and fierce bidding clash that only burst [...]